Literature DB >> 31685437

MSCs exosomal miR-1470 promotes the differentiation of CD4+CD25+FOXP3+ Tregs in asthmatic patients by inducing the expression of P27KIP1.

Yongxun Zhuansun1, Yumo Du2, Fengting Huang3, Lin Lin4, Rui Chen5, Shanping Jiang6, Jianguo Li7.   

Abstract

Exosomes derived from Mesenchymal Stem Cells (MSCs) possesses similar immunomodulatory effect as MSCs. It had been suggested that MSCs exosomes contain higher level of miR-1470 compared to exosomes derived from fibroblast. Here, we show that MSCs exosomal miR-1470 can elevate the proportion of CD4+CD25+FOXP3+ regulatory T cells (Tregs) in asthmatic patients. Moreover, mechanistic studies revealed that miR-1470 can promote the upregulation of P27KIP1 by directly targeting the 3' region of c-Jun mRNA. Furthermore, miR-1470 mimic transfection could significantly upregulate the proportion of CD4+CD25+FOXP3+ Tregs in CD4+ T cells. P27KIP1 knockdown via siRNA silencing significantly inhibited the proportion of CD4+CD25+FOXP3+ Tregs with over-expression of miR-1470, which indicates that miR-1470 induces the differentiation of CD4+CD25+FOXP3+ Tregs through P27KIP1.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bronchial asthma; Exosomes; Mesenchymal Stem Cells; P27KIP1; Regulatory T cells; microRNA

Mesh:

Substances:

Year:  2019        PMID: 31685437     DOI: 10.1016/j.intimp.2019.105981

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  10 in total

1.  Human bone marrow-mesenchymal stem cell-derived exosomal microRNA-188 reduces bronchial smooth muscle cell proliferation in asthma through suppressing the JARID2/Wnt/β-catenin axis.

Authors:  Lishen Shan; Si Liu; Qinzhen Zhang; Qianlan Zhou; Yunxiao Shang
Journal:  Cell Cycle       Date:  2022-01-02       Impact factor: 4.534

Review 2.  Immunosuppressive Effects of Mesenchymal Stem Cells-derived Exosomes.

Authors:  Xiaoli Qian; Nan An; Yifan Ren; Chenxin Yang; Xiaoling Zhang; Lisha Li
Journal:  Stem Cell Rev Rep       Date:  2021-04       Impact factor: 5.739

3.  Combination therapies enhance immunoregulatory properties of MIAMI cells.

Authors:  Fiorella Rossi; Hunter Noren; Leonor Sarria; Paul C Schiller; Lubov Nathanson; Vladimir Beljanski
Journal:  Stem Cell Res Ther       Date:  2019-12-18       Impact factor: 6.832

4.  Hypoxic hUCMSC-derived extracellular vesicles attenuate allergic airway inflammation and airway remodeling in chronic asthma mice.

Authors:  Liyang Dong; Ying Wang; Tingting Zheng; Yanan Pu; Yongbin Ma; Xin Qi; Wenzhe Zhang; Fei Xue; Zirui Shan; Jiameng Liu; Xuefeng Wang; Chaoming Mao
Journal:  Stem Cell Res Ther       Date:  2021-01-06       Impact factor: 6.832

5.  Preventive Effects of a Human Hematopoietic Mesenchymal Stem Cell (hHMSC) Therapy in Ovalbumin-Induced Food Allergy.

Authors:  Dong-Geon Lee; Yu-Jin Lee; Song-Hee Park; Hye-Ree Park; Hoon Kang; Jung-Eun Kim
Journal:  Biomedicines       Date:  2022-02-21

6.  Exosomal miR-221-3p Derived from Bone Marrow Mesenchymal Stem Cells Alleviates Asthma Progression by Targeting FGF2 and Inhibiting the ERK1/2 Signaling Pathway.

Authors:  Weike Liu; Hui Lin; Wuhui Nie; Jieting Wan; Qian Jiang; Aimei Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-10       Impact factor: 2.650

Review 7.  miR-aculous new avenues for cancer immunotherapy.

Authors:  William W Tang; Kaylyn M Bauer; Cindy Barba; Huseyin Atakan Ekiz; Ryan M O'Connell
Journal:  Front Immunol       Date:  2022-09-28       Impact factor: 8.786

8.  The Role of T Cells and Macrophages in Asthma Pathogenesis: A New Perspective on Mutual Crosstalk.

Authors:  Xueyi Zhu; Jie Cui; Jingjing Qin; Wuniqiemu Tulake; Fangzhou Teng; Weifeng Tang; Ying Wei; Jingcheng Dong
Journal:  Mediators Inflamm       Date:  2020-08-19       Impact factor: 4.711

Review 9.  Extracellular Vesicles and Asthma-More Than Just a Co-Existence.

Authors:  Bilal Alashkar Alhamwe; Daniel P Potaczek; Sarah Miethe; Fahd Alhamdan; Lukas Hintz; Arslan Magomedov; Holger Garn
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

Review 10.  Packaging and Delivery of Asthma Therapeutics.

Authors:  Bryan J Mathis; Misa Kusumoto; Alexander Zaboronok; Yuji Hiramatsu
Journal:  Pharmaceutics       Date:  2021-12-31       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.